Get Unlimited Plan at 75% OFF!
Sampre Nutritions
No Data Available
No Stocks
Unlock Smart Score
See Detailed Analysis & Insights
Unlock Insights
See Detailed Analysis & Insights
No Research Report
ROE
Avg ROE (3 Yrs) : NaN%
ROCE
Avg ROCE (3 Yrs) : NaN%
ROA
Avg ROA (3 Yrs) : NaN%
NPM
Avg NPM (3 Yrs) : NaN%
No Data Available
Unlock Management Data
See Detailed Analysis & Insights
Sampre Nutritions Ltd., incorporated in 1991 was promoted by The Gurbani Group, having its works at Medchal, in Andhra Pradesh. The Company is into the activity of manufacturing of Sugar Candies. The Company has been manufacturing candy products for its major customer, Cadbury India Ltd since August 1996. In 2000, it entered into agreement to manufacture 'DAIRY MILK ECLAIRS'.
During 1999, the Company commissioned two new projects for manufacture of Jelly in cups under the brand name 'GOLLUM' and 'Mr POPS'.
The company was also into the production of HERICOF Cough Lozenges for Ranbaxy Laboratories Ltd, whereby it manufactures CHESTO cough drops for export to its customer 'The Maharaja Organisation Ltd' of Sri Lanka.
During 2000, the Company got a major break-through during as it has commenced supplying confectionery products from April 2000 to the various depots of the Indian Airlines across the country
The Company launched 6 flavors of Hard Boiled Candy under 'Sampre' Brand in first phase during the year 2018.
During the year 2017, the Company was working as contract manufacturers of 'Eclairs' for Mondelez India Foods Private Limited (Formerly Cadbury India Ltd) and after expansion of production capacities, it became exclusive partner of Modelez India for manufacture of eclairs for Domestic and Export Market in 2022.
The Company set up wholly owned subsidiaries namely 'SAMPRE NUTRITIONS FZE CO' in Dubai, United Arab Emirates & 'SAMPRE NUTRITIONS HOLDING LIMITED' in England, United Kingdom during the year 2023.
Sampre Nutritions share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.
Market capitalization of Sampre Nutritions indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Sampre Nutritions is valued compared to its competitors.
Sampre Nutritions PE ratio helps investors understand what is the market value of each stock compared to Sampre Nutritions 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.
The PEG ratio of Sampre Nutritions evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.
Return on Equity (ROE) measures how effectively Sampre Nutritions generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.
Return on Capital Employed (ROCE) evaluates the profitability of Sampre Nutritions in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.
Total debt of Sampre Nutritions shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.
The Debt-to-Equity (DE) ratio of Sampre Nutritions compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.
CAGR shows the consistent growth rate of Sampre Nutritions over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.
Technical analysis of Sampre Nutritions helps investors get an insight into when they can enter or exit the stock. Key components of Sampre Nutritions Technical Analysis include:
There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.
There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Sampre Nutritions shares often struggle to rise above due to selling pressure.
Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Sampre Nutritions ’s financial health and profitability.
Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.
Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.
The financials of Sampre Nutritions provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.
The profit and loss statement of Sampre Nutritions highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Sampre Nutritions .
The balance sheet presents a snapshot of Sampre Nutritions ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.
Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.
Download the App